Literature DB >> 8855309

Identification of peptides specific for cerebrospinal fluid antibodies in multiple sclerosis by using phage libraries.

I Cortese1, R Tafi, L M Grimaldi, G Martino, A Nicosia, R Cortese.   

Abstract

The study of the origin and pathogenetic relevance of the oligoclonal antibodies present in the cerebrospinal fluid (CSF) of multiple sclerosis (MS) patients has been hampered by a lack of specific ligands. We recently reported a general strategy, based on phage-displayed random peptide libraries, to identify ligands for disease-specific antibodies even in the absence of any information on the nature of the pathologic antigen. With this procedure, we identified several peptides specifically recognized by antibodies present in the CSF of MS patients. Using these peptides as reagents, we demonstrated that they mimic different natural epitopes and react with antibodies enriched in the CSF of MS patients. Antibodies recognizing the selected peptides are commonly found with equal frequency in the sera of MS patients and of normal individuals. In contrast, the repertoire of CSF antibodies appears to be individual-specific and is probably the result of a nonspecific immunodysregulation rather than a stereotyped response to a single antigen/agent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855309      PMCID: PMC38284          DOI: 10.1073/pnas.93.20.11063

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides.

Authors:  A Luzzago; F Felici; A Tramontano; A Pessi; R Cortese
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

2.  Transient appearance of oligoclonal immunoglobulins and measles virus antibodies in the cerebrospinal fluid in a case of acute measles encephalitis.

Authors:  B Sköldenberg; A Carlström; M Forsgren; E Norrby
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

3.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

4.  The multiple sclerosis lesion.

Authors:  H F McFarland
Journal:  Ann Neurol       Date:  1995-04       Impact factor: 10.422

5.  Immunoglobulins in multiple sclerosis and infections of the nervous system.

Authors:  H Link; R Müller
Journal:  Arch Neurol       Date:  1971-10

6.  Monoclonal antibodies that recognise filamentous phage: tools for phage display technology.

Authors:  L Dente; G Cesareni; G Micheli; F Felici; A Folgori; A Luzzago; P Monaci; A Nicosia; P Delmastro
Journal:  Gene       Date:  1994-10-11       Impact factor: 3.688

7.  Chronic progressive panencephalitis due to rubella virus simulating subacute sclerosing panencephalitis.

Authors:  M L Weil; H Itabashi; N E Cremer; L Oshiro; E H Lennette; L Carnay
Journal:  N Engl J Med       Date:  1975-05-08       Impact factor: 91.245

8.  Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

Authors:  H Link; V Kostulas
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

9.  The use and abuse of the cerebrospinal fluid IgG profile in the adult: a practical evaluation.

Authors:  L A Hershey; J L Trotter
Journal:  Ann Neurol       Date:  1980-10       Impact factor: 10.422

10.  Advances in the understanding and treatment of multiple sclerosis. Boston, Massachusetts, USA, 28-29 October 1992.

Authors:  S C Reingold
Journal:  J Neuroimmunol       Date:  1993-05       Impact factor: 3.478

View more
  20 in total

1.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Intrathecally synthesized IgG in multiple sclerosis cerebrospinal fluid recognizes identical epitopes over time.

Authors:  Xiaoli Yu; Mark Burgoon; Miyoko Green; Olga Barmina; Kathryn Dennison; Tiffany Pointon; Molly Davis; Don Gilden
Journal:  J Neuroimmunol       Date:  2011-11-12       Impact factor: 3.478

3.  Use of Peptide library screening to detect a previously unknown linear diagnostic epitope: proof of principle by use of lyme disease sera.

Authors:  Carl V Hamby; Marta Llibre; Sandeepa Utpat; Gary P Wormser
Journal:  Clin Diagn Lab Immunol       Date:  2005-07

4.  Antibody biomarker discovery through in vitro directed evolution of consensus recognition epitopes.

Authors:  John T Ballew; Joseph A Murray; Pekka Collin; Markku Mäki; Martin F Kagnoff; Katri Kaukinen; Patrick S Daugherty
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-12       Impact factor: 11.205

Review 5.  Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders.

Authors:  Panos Stathopoulos; Harry Alexopoulos; Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2015-01-27       Impact factor: 42.937

6.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

7.  Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis.

Authors:  Sabine Cepok; Dun Zhou; Rajneesh Srivastava; Stefan Nessler; Susanne Stei; Konrad Büssow; Norbert Sommer; Bernhard Hemmer
Journal:  J Clin Invest       Date:  2005-04-14       Impact factor: 14.808

Review 8.  The potential role of B cell-targeted therapies in multiple sclerosis.

Authors:  Aaron Boster; Daniel P Ankeny; Michael K Racke
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

9.  Screening random peptide libraries with subacute sclerosing panencephalitis brain-derived recombinant antibodies identifies multiple epitopes in the C-terminal region of the measles virus nucleocapsid protein.

Authors:  Gregory P Owens; Andrew J Shearer; Xiaoli Yu; Alanna M Ritchie; Kathryne M Keays; Jeffrey L Bennett; Donald H Gilden; Mark P Burgoon
Journal:  J Virol       Date:  2006-12       Impact factor: 5.103

10.  Proteomic strategies in multiple sclerosis and its animal models.

Authors:  Stella Elkabes; Hong Li
Journal:  Proteomics Clin Appl       Date:  2007-10-16       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.